Caption: Chairman and President Pan Gang speaking

 

Caption: Scene of the 2023 Investor Day

                

HOHHOT, China, July 20, 2023 /Xinhua-AsiaNet/--
 

On July 14, Yili held its 2023 Investor Day, and its management sat down with hundreds of investors and analysts from the world's top investment institutions for in-depth exchanges. Pan Gang, Chairman of Yili Group, said in his speech that Yili will continue to be a pioneer of a new-type supply chain, a pioneer in digitalization and a practitioner of sustainable development, and make more contributions and create greater value for consumers, investors, and human health and well-being. In the post-pandemic era, pro-health functional products that serve the whole population will become the core driver of the development of dairy products. Yili is an early entrant in health sector. In recent years, Yili has launched functional pro-health nutrition products such as A2. This year it launched the world's first functional milk product capable of blood sugar regulation, and the world's first room-temperature organic pure milk with active lactoferrin, among other subdivided functional pro-health dairy products. The launch of new pro-health products one after another was enabled by Yili's input and breakthrough in forward-looking innovative technology. Yili was the first to break the technological barriers and increase the retention rate of lactoferrin in room-temperature pure milk from 10% to more than 90%. In addition, Yili has started the construction of its lactoferrin factory in New Zealand, and after it is completed and put into operation, Yili will rank among the top three lactoferrin producers in the world, which will greatly enhance Yili's global influence in the industry. Yili is making multiple breakthroughs in similar cutting-edge technologies, with the expectation of opening up new space for performance growth. At the conference, Yili also introduced the latest development and growth potential of five of its brands: Satine, AMBPOMIAL, Jinlingguan, Chocliz and XinHuo. http://mrem.bernama.com/viewsm.php?idm=46623